List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Deciduous Therapeutics Investor

Developer of novel therapeutics designed for the treatment of age-related diseases. The company's novel molecules can activate a critical endogenous immune surveillance mechanism to selectively remove senescent cells, enabling healthcare providers to treat several classes of age-related Therapeutics 2025 : Valuation, ?

Investors

Connections from

Technology: Biotechnology
Estimated Revenue: 26.5M.
Founded Date: 2019.0
Headquarters: 953 Indiana St, San Francisco, CA 94107
Employee Number: 14
Register and Claim Ownership